KONINKLIJKE PHILIPS NV (PHI1.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:PHI1 - NL0000009538 - Common Stock
23.28 EUR
+0.62 (+2.74%)
Taking everything into account, PHI1 scores 3 out of 10 in our fundamental rating. PHI1 was compared to 65 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PHI1 have multiple concerns. PHI1 has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year PHI1 was profitable.
PHI1 had a positive operating cash flow in the past year.
In multiple years PHI1 reported negative net income over the last 5 years.
Of the past 5 years PHI1 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.61%, PHI1 is doing worse than 64.62% of the companies in the same industry.
The Return On Equity of PHI1 (1.56%) is worse than 64.62% of its industry peers.
PHI1 has a Return On Invested Capital of 4.00%. This is in the lower half of the industry: PHI1 underperforms 63.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHI1 has a worse Profit Margin (0.91%) than 64.62% of its industry peers.
Looking at the Operating Margin, with a value of 6.11%, PHI1 is in line with its industry, outperforming 41.54% of the companies in the same industry.
In the last couple of years the Operating Margin of PHI1 has declined.
PHI1's Gross Margin of 43.85% is on the low side compared to the rest of the industry. PHI1 is outperformed by 73.85% of its industry peers.
In the last couple of years the Gross Margin of PHI1 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHI1 is destroying value.
The number of shares outstanding for PHI1 has been reduced compared to 1 year ago.
The number of shares outstanding for PHI1 has been increased compared to 5 years ago.
The debt/assets ratio for PHI1 is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.93 indicates that PHI1 is not a great score, but indicates only limited risk for bankruptcy at the moment.
PHI1 has a Altman-Z score of 1.93. This is comparable to the rest of the industry: PHI1 outperforms 41.54% of its industry peers.
PHI1 has a debt to FCF ratio of 19.41. This is a negative value and a sign of low solvency as PHI1 would need 19.41 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 19.41, PHI1 is doing worse than 61.54% of the companies in the same industry.
A Debt/Equity ratio of 0.69 indicates that PHI1 is somewhat dependend on debt financing.
The Debt to Equity ratio of PHI1 (0.69) is worse than 75.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.93 |
ROIC/WACC0.62
WACC6.49%
2.3 Liquidity
A Current Ratio of 1.26 indicates that PHI1 should not have too much problems paying its short term obligations.
PHI1 has a worse Current ratio (1.26) than 69.23% of its industry peers.
PHI1 has a Quick Ratio of 1.26. This is a bad value and indicates that PHI1 is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.81, PHI1 is not doing good in the industry: 72.31% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 15.15% over the past year.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
PHI1 shows a decrease in Revenue. In the last year, the revenue decreased by -0.81%.
PHI1 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.00% yearly.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
3.2 Future
PHI1 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.05% yearly.
Based on estimates for the next years, PHI1 will show a small growth in Revenue. The Revenue will grow by 3.41% on average per year.
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y13.05%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.41%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.73, which indicates a correct valuation of PHI1.
Based on the Price/Earnings ratio, PHI1 is valued cheaply inside the industry as 93.85% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.46, PHI1 is valued a bit cheaper.
A Price/Forward Earnings ratio of 15.21 indicates a correct valuation of PHI1.
PHI1's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PHI1 is cheaper than 73.85% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.10, PHI1 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.73 | ||
| Fwd PE | 15.21 |
4.2 Price Multiples
PHI1's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PHI1 is cheaper than 75.38% of the companies in the same industry.
PHI1's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 51.65 | ||
| EV/EBITDA | 12.5 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHI1 does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)66.21
PEG (5Y)N/A
EPS Next 2Y5.1%
EPS Next 3Y7.59%
5. Dividend
5.1 Amount
No dividends for PHI1!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:PHI1 (12/5/2025, 7:00:00 PM)
23.28
+0.62 (+2.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners44.69%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap22.42B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target27.57 (18.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)1.37%
PT rev (3m)0.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.38%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-0.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.73 | ||
| Fwd PE | 15.21 | ||
| P/S | 1.26 | ||
| P/FCF | 51.65 | ||
| P/OCF | 20.4 | ||
| P/B | 2.16 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.5 |
EPS(TTM)1.48
EY6.36%
EPS(NY)1.53
Fwd EY6.57%
FCF(TTM)0.45
FCFY1.94%
OCF(TTM)1.14
OCFY4.9%
SpS18.54
BVpS10.78
TBVpS-1.76
PEG (NY)66.21
PEG (5Y)N/A
Graham Number18.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4% | ||
| ROICexc | 4.43% | ||
| ROICexgc | 14.55% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.93 |
F-Score8
WACC6.49%
ROIC/WACC0.62
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y13.05%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.41%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.14%
EBIT Next 3Y21.01%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NV / PHI1.DE FAQ
What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NV (PHI1.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to PHI1.DE.
What is the valuation status of KONINKLIJKE PHILIPS NV (PHI1.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHI1.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for KONINKLIJKE PHILIPS NV?
KONINKLIJKE PHILIPS NV (PHI1.DE) has a profitability rating of 2 / 10.
How financially healthy is KONINKLIJKE PHILIPS NV?
The financial health rating of KONINKLIJKE PHILIPS NV (PHI1.DE) is 2 / 10.
What is the earnings growth outlook for KONINKLIJKE PHILIPS NV?
The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NV (PHI1.DE) is expected to grow by 0.24% in the next year.